StockNews.com started coverage on shares of 22nd Century Group (NASDAQ:XXII – Get Free Report) in a research note issued on Monday. The brokerage set a “sell” rating on the biotechnology company’s stock.
22nd Century Group Stock Up 20.3 %
Shares of NASDAQ:XXII opened at $0.11 on Monday. 22nd Century Group has a 1 year low of $0.08 and a 1 year high of $5.28. The stock has a 50-day simple moving average of $0.15 and a 200-day simple moving average of $0.54. The company has a debt-to-equity ratio of 1.59, a quick ratio of 0.93 and a current ratio of 1.09. The stock has a market capitalization of $5.03 million, a P/E ratio of 0.00 and a beta of 1.45.
22nd Century Group (NASDAQ:XXII – Get Free Report) last announced its earnings results on Tuesday, November 12th. The biotechnology company reported ($0.54) EPS for the quarter. The company had revenue of $5.95 million for the quarter. 22nd Century Group had a negative net margin of 144.09% and a negative return on equity of 380.39%.
Institutional Inflows and Outflows
About 22nd Century Group
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
Read More
- Five stocks we like better than 22nd Century Group
- Best Stocks Under $5.00
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- Using the MarketBeat Dividend Yield Calculator
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- What is a buyback in stocks? A comprehensive guide for investors
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.